Literature DB >> 12097577

Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription.

Edward E Hinzman1, John N Barr, Gail W Wertz.   

Abstract

Vesicular stomatitis virus (VSV), the prototypic rhabdovirus, has a nonsegmented negative-sense RNA genome with five genes flanked by 3' leader and 5' trailer sequences. Transcription of VSV mRNAs is obligatorily sequential, starting from a single 3' polymerase entry site, and termination of an upstream mRNA is essential for transcription of a downstream gene. cis-acting signals for transcription of VSV mRNAs are present within the leader region, at the leader-N junction, and at the internal gene junctions. The gene junctions of VSV consist of a conserved 23-nucleotide region that includes the gene end sequence of the upstream gene, 3'-AUACU7-5', a nontranscribed intergenic dinucleotide, 3'-G/CA-5', and the gene start sequence, 3'-UUGUCNNUAG-5', at the beginning of the gene immediately downstream. Previous work has shown that the gene end sequence and intergenic region are sufficient to signal polyadenylation and termination of VSV transcripts. Mutagenesis of the gene start sequence has determined the importance of this region in the processes of initiation and 5'-end modification of mRNAs. However, because the gene end sequence is positioned directly upstream of the gene start sequence in the gene junction, and because of the requirement for termination of the upstream gene prior to transcription of the downstream gene, it has not been possible to investigate whether the gene end sequence contributes to transcription of the downstream gene. In this study, we inserted an additional gene end sequence upstream of the gene junction in a subgenomic replicon of VSV, which extended the intergenic region from 2 to 88 nucleotides. This duplication of termination signals allowed us to separate the signals required for termination from those required for initiation. We investigated the effect that the upstream gene end sequences had on downstream mRNA transcription. Our data show that the U7 tract of the upstream gene end sequence is necessary for optimal transcription of the downstream gene, independent of its role in termination of the upstream gene. Altering the sequence or changing the length of the U tract directly upstream of the gene start sequence significantly decreased transcription of the downstream gene. These results show that the U tract is a multifunctional region that is required not only for polyadenylation and termination of the upstream mRNA but also for efficient transcription of the downstream gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097577      PMCID: PMC136381          DOI: 10.1128/jvi.76.15.7632-7641.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.

Authors:  G W Wertz; V P Perepelitsa; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA.

Authors:  G W Wertz; S Whelan; A LeGrone; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.

Authors:  L A Ball; C R Pringle; B Flanagan; V P Perepelitsa; G W Wertz
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions.

Authors:  L N Hwang; N Englund; A K Pattnaik
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus.

Authors:  M J Schnell; L Buonocore; M A Whitt; J K Rose
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication.

Authors:  S P Whelan; G W Wertz
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Overlapping signals for transcription and replication at the 3' terminus of the vesicular stomatitis virus genome.

Authors:  T Li; A K Pattnaik
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  14 in total

1.  Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression.

Authors:  Gail W Wertz; Robin Moudy; L Andrew Ball
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.

Authors:  Kristina Brauburger; Yannik Boehmann; Yoshimi Tsuda; Thomas Hoenen; Judith Olejnik; Michael Schümann; Hideki Ebihara; Elke Mühlberger
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

4.  Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal.

Authors:  Christian J Sauder; Laurie Ngo; Vahan Simonyan; Yu Cong; Cheryl Zhang; Malen Link; Tahir Malik; Steven A Rubin
Journal:  Virus Genes       Date:  2015-05-12       Impact factor: 2.332

5.  Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.

Authors:  Jianrong Li; John S Chorba; Sean P J Whelan
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior.

Authors:  Kristina Brauburger; Yannik Boehmann; Verena Krähling; Elke Mühlberger
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Selection for gene junction sequences important for VSV transcription.

Authors:  Edward E Hinzman; John N Barr; Gail W Wertz
Journal:  Virology       Date:  2008-09-09       Impact factor: 3.616

8.  A temperature sensitive VSV identifies L protein residues that affect transcription but not replication.

Authors:  Summer E Galloway; Gail W Wertz
Journal:  Virology       Date:  2009-04-22       Impact factor: 3.616

9.  Role of intergenic sequences in newcastle disease virus RNA transcription and pathogenesis.

Authors:  Yongqi Yan; Siba K Samal
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

10.  The VSV polymerase can initiate at mRNA start sites located either up or downstream of a transcription termination signal but size of the intervening intergenic region affects efficiency of initiation.

Authors:  J N Barr; Xiaoling Tang; Edward Hinzman; Ruizhong Shen; Gail W Wertz
Journal:  Virology       Date:  2008-01-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.